These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9182381)

  • 1. [Prostatic cancer: an expensive dilemma].
    Borre M; Nerstrøm B; Overgaard J
    Ugeskr Laeger; 1997 Apr; 159(17):2534-7. PubMed ID: 9182381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of prostate carcinoma based on a Danish population treated with no intent to cure.
    Borre M; Nerstrøm B; Overgaard J
    Cancer; 1997 Sep; 80(5):917-28. PubMed ID: 9307192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technological changes in the management of prostate cancer result in increased healthcare costs--a retrospective study in a defined Swedish population.
    Sennfält K; Carlsson P; Thorfinn J; Frisk J; Henriksson M; Varenhorst E
    Scand J Urol Nephrol; 2003; 37(3):226-31. PubMed ID: 12775282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma of the prostate: an expensive way to die.
    Piper NY; Kusada L; Lance R; Foley J; Moul J; Seay T
    Prostate Cancer Prostatic Dis; 2002; 5(2):164-6. PubMed ID: 12497008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer--prevalence-based healthcare costs.
    Norlund A; Alvegård T; Lithman T; Merlo J; Noreen D
    Scand J Urol Nephrol; 2003; 37(5):371-5. PubMed ID: 14594683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morbidity among patients with clinically localized prostatic cancer. A registry-based case-control study].
    Brasso K; Friis S; Juel K; Jørgensen T; Iversen P
    Ugeskr Laeger; 2001 Oct; 163(41):5673-6. PubMed ID: 11665471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative cost pattern comparison of prostate cancer treatments.
    Wilson LS; Tesoro R; Elkin EP; Sadetsky N; Broering JM; Latini DM; DuChane J; Mody RR; Carroll PR
    Cancer; 2007 Feb; 109(3):518-27. PubMed ID: 17186528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment costs of prostate cancer in the first year after diagnosis: a short-term cost of illness study for France, Germany, Italy, Spain and the UK.
    Fourcade RO; Benedict A; Black LK; Stokes ME; Alcaraz A; Castro R
    BJU Int; 2010 Jan; 105(1):49-56. PubMed ID: 20132102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of prostate cancer, California, 1998.
    Max W; Rice DP; Sung HY; Michel M; Breuer W; Zhang X
    Cancer; 2002 Jun; 94(11):2906-13. PubMed ID: 12115378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.
    Grover SA; Coupal L; Zowall H; Rajan R; Trachtenberg J; Elhilali M; Chetner M; Goldenberg L
    CMAJ; 2000 Apr; 162(7):977-83. PubMed ID: 10763395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dilemma of prostate cancer--a growing human and economic burden irrespective of treatment strategies.
    Borre M; Nerstrøm B; Overgaard J
    Acta Oncol; 1997; 36(7):681-7. PubMed ID: 9490083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer in Denmark. Incidence, morbidity and mortality.
    Brasso K; Iverson P
    Scand J Urol Nephrol Suppl; 1999; 203():29-33. PubMed ID: 10636567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prostate cancer: medicoeconomic aspects].
    Kanso C; Etner J; Debré B; Zerbib M
    Prog Urol; 2010 Feb; 20(2):85-90. PubMed ID: 20142048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer in Maiduguri.
    Yawe KT; Tahir MB; Nggada HA
    West Afr J Med; 2006; 25(4):298-300. PubMed ID: 17402521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma.
    Brandeis J; Pashos CL; Henning JM; Litwin MS
    Cancer; 2000 Oct; 89(8):1792-9. PubMed ID: 11042575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economical data and advanced prostate carcinoma: do we need new guidelines for decision making?
    Rohde V; Wellmann A; Fogt F; Weidner W; Katalinic A
    Oncol Rep; 2002; 9(6):1185-8. PubMed ID: 12375016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying potential need for cancer palliation in Nova Scotia.
    Johnston GM; Gibbons L; Burge FI; Dewar RA; Cummings I; Levy IG
    CMAJ; 1998 Jun; 158(13):1691-8. PubMed ID: 9676544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.